SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo
Medizinische Hochschule Hannover | Carl-Neuberg-Str.1 | 30625 Hannover | Tel.:(+49) 0511-532-0

Publikationen



2019:

Hülsdünker J, Thomas OS, Haring E, Unger S, Gonzalo Núñez N, Tugues S, Gao Z, Duquesne S, Cywes-Bentley C, Oyardi O, Kirschnek S, Schmitt-Graeff A, Pabst O, Koenecke C, Duyster J, Apostolova P, Blaser MJ, Becher B, Pier GB, Häcker G, Zeiser R. Immunization against poly-N-acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversity. Proc Natl Acad Sci U S A. 2019 Sep 16. pii: 201908549. doi: 10.1073/pnas.1908549116. [Epub ahead of print] PubMed PMID: 31527267.

Ruutu T, van der Werf S, van Biezen A, Backman JT, Peczynski C, Kröger N, Mohty M, Nagler A, Montoto S, Langebrake C, Niederwieser D, Peric Z, Koenecke C, Duarte RF, Basak G. Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT. Bone Marrow Transplant. 2019 Jun 3. doi: 10.1038/s41409-019-0579-0. [Epub ahead of print] PubMed PMID: 31160806.

Kröger N, Eikema DJ, Köster L, Beelen D, de Wreede LC, Finke J, Koenecke C, Niederwieser D,  Bornhäuser M, Schoenland S, Potter V, Wolschke C, Maertens J, Theobald M, Kobbe G, Itälä-Remes M, Wulf G, Kahls P, Forcade E, Greinix H, Masszi T, Yakoub-Agha I, Chalandon Y, Robin M; Chronic Malignancies Working Party of the European Society for Blood Marrow Transplantation. Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia. Br J Haematol. 2019 May;185(4):725-732. doi: 10.1111/bjh.15819. Epub 2019 Feb 28. PubMed PMID: 30820933.

Tan L, Sandrock I, Odak I, Aizenbud Y, Wilharm A, Barros-Martins J, Tabib Y, Borchers A, Amado T, Gangoda L, Herold MJ, Schmidt-Supprian M, Kisielow J, Silva-Santos B, Koenecke C, Hovav AH, Krebs C, Prinz *, Ravens S*. Single-Cell Transcriptomics Identifies the Adaptation of Scart1(+) Vγ6(+) T Cells to Skin Residency as Activated Effector Cells. Cell Rep. 2019 Jun 18;27(12):3657-3671.e4. doi: 10.1016/j.celrep.2019.05.064. PubMed PMID: 31216482.
*equal contribution

Odak I*, Raha S*, Schultze-Florey C, Tavil S, Ravens S, Ganser A, Förster R, Prinz I**, Koenecke C**. Focusing of the regulatory T cell repertoire after allogeneic stem cell transplantation indicates protection from graft-versus-host disease. Haematologica. 2019 Apr 24. pii: haematol.2019.218206. doi: 10.3324/haematol.2019.218206. [Epub ahead of print] PubMed PMID: 31018979.
*equal contribution, ** shared senior authorship

Gödecke V, Schmidt JJ, Bräsen JH, Koenecke C, Haller H. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies]. Internist (Berl). 2019 Jan 11. doi: 10.1007/s00108-018-0538-7. [Epub ahead of print] Review. German. PubMed PMID: 30635666

2018:

Bak S, Tischer S, Dragon A, Ravens S, Pape L, Koenecke C, Oelke M, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B. Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression. Front Immunol. 2018 Dec 17;9:2953. doi: 10.3389/fimmu.2018.02953. eCollection 2018. PubMed PMID: 30619313; PubMed Central PMCID: PMC6304429.

Krauter J, Fiedler W, Schlenk RF, Paschka P, Thol F, Lübbert M, Wattad M, Verbeek M, Könecke C, Neuhaus B, Papkalla A, Kebenko M, Janning M, Döhner K, Gaidzik VI, Becker H, Greil C, Reimer P, Götze KS, Döhner H, Ganser A, Heuser M. Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial). Br J Haematol. 2018 Oct;183(2):235-241. doi: 10.1111/bjh.15546. PubMed PMID: 30378121.

Moiseev IS, Tsvetkova T, Aljurf M, Alnounou RM, Bogardt J, Chalandon Y, Drokov MY, Dvirnyk V, Faraci M, Friis LS, Giglio F, Greinix HT, Kornblit BT, Koelper C, Koenecke C, Lewandowski K, Niederwieser D, Passweg JR, Peczynski C, Penack O, Peric Z, Piekarska A, Ronchi PE, Rovo A, Rzepecki P, Scuderi F, Sigrist D, Siitonen SM, Stoelzel F, Sulek K, Tsakiris DA, Wilkowojska U, Duarte RF, Ruutu T, Basak GW. Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT. Bone Marrow Transplant. 2018 Oct 25. doi: 10.1038/s41409-018-0374-3. [Epub ahead of print] PubMed PMID: 30361500.

Ziegler AK, Abend M, Port M, Dammann E, Homeyer RS, Eder M, Ganser A, Schrem H, Koenecke C. Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2018 Oct 18. doi: 10.1038/s41409-018-0359-2. [Epub ahead of print] PubMed PMID: 30337701.

Thol F, Gabdoulline R, Liebich A, Klement P, Schiller J, Kandziora C, Hambach L, Stadler M, Koenecke C, Flintrop M, Pankratz M, Wichmann M, Neziri B, Büttner K, Heida B, Klesse S, Chaturvedi A, Kloos A, Göhring G, Schlegelberger B, Gaidzik VI, Bullinger L, Fiedler W, Heim A, Hamwi I, Eder M, Krauter J, Schlenk RF, Paschka P, Döhner K, Döhner H, Ganser A, Heuser M. Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML. Blood. 2018 Oct 18;132(16):1703-1713. doi: 10.1182/blood-2018-02-829911. Epub 2018 Sep 6. PubMed PMID: 30190321.

Lueck C, Stadler M, Koenecke C, Hoeper MM, Dammann E, Schneider A, Kielstein JT, Ganser A, Eder M, Beutel G. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med. 2018 Sep;44(9):1483-1492. doi: 10.1007/s00134-018-5347-x. Epub 2018 Aug 23. PubMed PMID: 30141173.

Schultze-Florey RE, Tischer S, Kuhlmann L, Hundsdoerfer P, Koch A, Anagnostopoulos I, Ravens S, Goudeva L, Schultze-Florey C, Koenecke C, Blasczyk R, Koehl U, Heuft HG, Prinz I, Eiz-Vesper B, Maecker-Kolhoff B. Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease. Front Immunol. 2018 Jun 27;9:1475. doi: 10.3389/fimmu.2018.01475. eCollection 2018. PubMed PMID: 29997626; PubMed Central PMCID: PMC6030255

Koenecke C, Krueger A. MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease. Front Immunol. 2018 May 7;9:992. doi: 10.3389/fimmu.2018.00992. eCollection 2018. Review. PubMed PMID: 29867969; PubMed Central PMCID: PMC5949326

Hammer Q, Rückert T, Borst EM, Dunst J, Haubner A, Durek P, Heinrich F, Gasparoni G, Babic M, Tomic A, Pietra G, Nienen M, Blau IW, Hofmann J, Na IK, Prinz I, Koenecke C, Hemmati P, Babel N, Arnold R, Walter J, Thurley K, Mashreghi MF, Messerle M, Romagnani C. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells. Nat Immunol. 2018 Apr 9. doi: 10.1038/s41590-018-0082-6. [Epub ahead of print] PubMed PMID: 29632329.

Garderet L, Iacobelli S, Koster L, Goldschmidt H, Johansson JE, Bourhis JH, Krejci M, Leleu X, Potter M, Blaise D, Koenecke C, Peschel C, Radocha J, Metzner B, Lenain P, Schäfer-Eckart K, Pohlreich D, Grasso M, Caillot D, Einsele H, Ladetto M, Schönland S, Kröger N. Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma. Biol Blood Marrow Transplant. 2018 Feb 3. pii: S1083-8791(18)30052-1. doi: 10.1016/j.bbmt.2018.01.035. [Epub ahead of print] PubMed PMID: 29408334.

Ravens S, Hengst J, Schlapphoff V, Deterding K, Dhingra A, Schultze-Florey C, Koenecke C, Cornberg M, Wedemeyer H, Prinz I. Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy. Front Immunol. 2018 Mar 16;9:510. doi: 10.3389/fimmu.2018.00510. eCollection 2018. PubMed PMID: 29616028; PubMed Central PMCID: PMC5864898.

2017:

Scheid C, de Wreede L, van Biezen A, Koenecke C, Göhring G, Volin L, Maertens J, Finke J, Passweg J, Beelen D, Cornelissen JJ, Itälä-Remes M, Chevallier P, Russell N, Petersen E, Milpied N, Richard Espiga C, Peniket A, Sierra J, Mufti G, Crawley C, Veelken JH, Ljungman P, Cahn JY, Alessandrino EP, de Witte T, Robin M, Kröger N. Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party. Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.171. [Epub ahead of print] PubMed PMID: 28892084.

Ogonek J, Verma K, Schultze-Florey C, Varanasi P, Luther S, Schweier P, Kühnau W, Göhring G, Dammann E, Stadler M, Ganser A, Koehl U, Koenecke C, Weissinger EM, Hambach L. Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation. J Immunol. 2017 Jun 19. pii: ji1601992. doi: 10.4049/jimmunol.1601992. [Epub ahead of print] PubMed PMID: 28630092.

Heuser M, Gabdoulline R, Löffeld P, Dobbernack V, Kreimeyer H, Pankratz M, Flintrop M, Liebich A, Klesse S, Panagiota V, Stadler M, Wichmann M, Shahswar R, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Geffers R, Schlegelberger B, Göhring G, Kreipe HH, Germing U, Ganser A, Kröger N, Koenecke C*, Thol F*. Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation. Ann Hematol. 2017 Jun 13. doi: 10.1007/s00277-017-3027-5. [Epub ahead of print] PubMed PMID: 28612220.
*equal contribution

Kröger N, Panagiota V, Badbaran A, Zabelina T, Triviai I, Araujo Cruz MM, Shahswar R, Ayuk F, Gehlhaar M, Wolschke C, Bollin R, Walter C, Dugas M, Wiehlmann L, Lehmann U, Koenecke C, Chaturvedi A, Alchalby H, Stadler M, Eder M, Christopeit M, Göhring G, Koenigsmann M, Schlegelberger B, Kreipe HH, Ganser A, Stocking C, Fehse B, Thol F, Heuser M. Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2017 Apr 4. pii: S1083-8791(17)30385-3. doi: 10.1016/j.bbmt.2017.03.034. [Epub ahead of print] PubMed PMID: 28389256.

Ravens S, Schultze-Florey C, Raha S, Sandrock I, Drenker M, Oberdörfer L, Reinhardt A, Ravens I, Beck M, Geffers R, von Kaisenberg C, Heuser M, Thol F, Ganser A, Förster R, Koenecke C*, Prinz I*. Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection. Nat Immunol. 2017 Feb 20. doi: 10.1038/ni.3686. [Epub ahead of print] PubMed PMID: 28218745
*equal contribution

Sethi MK, Thol F, Stadler M, Heuser M, Ganser A, Koenecke C*, Pabst O*. VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation. PLoS One. 2017 Jan 17;12(1):e0168096. doi: 10.1371/journal.pone.0168096. PubMed PMID: 28095438
*equal contribution

2016:

Weissinger EM, Human C, Metzger J, Hambach L, Wolf D, Greinix HT, Dickinson AM, Mullen W, Jonigk D, Kuzmina Z, Kreipe H, Schweier P, Böhm O, Türüchanow I, Ihlenburg-Schwarz D, Raad J, Durban A, Schiemann M, Könecke C, Diedrich H, Holler E, Beutel G, Krauter J, Ganser A, Stadler M. The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation. Leukemia. 2016 Sep 28. doi: 10.1038/leu.2016.259. [Epub ahead of print] PubMed PMID: 27677743.

Rausch L, Koenecke C, Koch HF, Kaltenborn A, Emmanouilidis N, Pape L, Lehner F, Arelin V, Baumann U, Schrem H. Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation. Transplant Res. 2016 Aug 2;5:6. doi: 10.1186/s13737-016-0036-1. eCollection 2016. PubMed PMID: 27486513; PubMed Central PMCID: PMC4970231.

Endig J, Buitrago-Molina LE, Marhenke S, Reisinger F, Saborowski A, Schütt J, Limbourg F, Könecke C, Schreder A, Michael A, Misslitz AC, Healy ME, Geffers R, Clavel T, Haller D, Unger K, Finegold M, Weber A, Manns MP, Longerich T, Heikenwälder M, Vogel A. Dual Role of the Adaptive Immune System in Liver Injury and Hepatocellular Carcinoma Development. Cancer Cell. 2016 Jul 27. pii: S1535-6108(16)30269-0. doi: 10.1016/j.ccell.2016.06.009. [Epub ahead of print] PubMed PMID: 27478039

Raha S*, Raud B*, Oberdörfer L, Castro CN, Schreder A, Freitag J, Longerich T, Lochner M, Sparwasser T, Berod L*, Koenecke C*, Prinz I*. Disruption of de novo fatty acid synthesis via acetyl-CoA carboxylase 1 inhibition prevents acute graft-versus-host disease. Eur J Immunol. 2016 Jun 24. doi: 10.1002/eji.201546152. [Epub ahead of print] PubMed PMID: 27338930.
*equal contribution

Koenecke C, Heim D, van Biezen A, Heuser M, Aljurf M, Kyrcz-Krzemien S, Volin L, de Souza CA, Gedde-Dahl T, Sengeloev H, Schanz U, Komarnicki M, Arroyo CH, Tholouli E, Gluckman E, Esquirol A, Yakoub-Agha I, Gürman G, Olavarria E, Kröger N. Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party. Bone Marrow Transplant. 2016 Apr 25. doi: 10.1038/bmt.2016.97. [Epub ahead of print] PubMed PMID: 27111041.


Lee CW, Wohlan K, Dallmann I, Förster R, Ganser A, Krueger A, Scherr M, Eder M, Koenecke C. miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation. J Immunol. 2016 Mar 23. pii: 1502152. [Epub ahead of print] PubMed PMID: 27009493.


2015:

Schreder A, Moschovakis GL, Halle S, Schlue J, Lee CW, Schippers A, David S, Bernhardt G, Ganser A, Pabst O, Förster R, Koenecke C. Differential effects of gut-homing molecules CC chemokine receptor 9 and integrin-beta7 during acute GvHD of the liver. Biol Blood Marrow Transplant. 2015 Sep 5. pii: S1083-8791(15)00599-6. doi: 10.1016/j.bbmt.2015.08.038. [Epub ahead of print] PubMed PMID: 26348893.

Heuser M, Meggendorfer M, Cruz MM, Fabisch J, Klesse S, Köhler L, Göhring G, Ganster C, Shirneshan K, Gutermuth A, Cerny-Reiterer S, Krönke J, Panagiota V, Haferlach C, Koenecke C, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Ehrlich S, Stamer K, Döhner K, Valent P, Schlegelberger B, Kroeger N, Ganser A, Haase D, Haferlach T, Thol F. Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q. Leukemia. 2015 Feb 24. doi: 10.1038/leu.2015.49. [Epub ahead of print] PubMed PMID: 25792355.

Kashani E, Föhse L, Raha S, Sandrock I, Oberdörfer L, Koenecke C, Suerbaum S, Weiss S, Prinz I. A clonotypic Vγ4Jγ1/Vδ5Dδ2Jδ1 innate γδ T-cell population restricted to the CCR6(+)CD27(-) subset. Nat Commun. 2015 Mar 13;6:6477. doi: 10.1038/ncomms7477. PubMed PMID: 25765849.

Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, Beguin Y, Lang P, Koenecke C, Sykora KW, Te Boome L, van Biezen A, van der Werf S, Mohty M, de Witte T, Marsh J, Dreger P, Kröger N, Duarte R, Ruutu T. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT. Am J Transplant. 2015 Mar;15(3):705-14. doi: 10.1111/ajt.13017. Epub 2015 Feb 3. PubMed PMID: 25648262.


2014:


Thol F, Scherr M, Kirchner A, Shahswar R, Battmer K, Kade S, Chaturvedi A,Koenecke C, Stadler M, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Bug G,Ottmann O, Hofmann W, Kröger N, Fiedler W, Schlenk R, Döhner K, Döhner H, Krauter J, Eder M, Ganser A, Heuser M. Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia. Haematologica. 2014 Dec 31. pii: haematol.2014.120345. [Epub ahead of print] PubMed PMID: 25552704.

Koenecke C, Göhring G, de Wreede LC, van Biezen A, Scheid C, Volin L, Maertens J, Finke J, Schaap N, Robin M, Passweg J, Cornelissen J, Beelen D, Heuser M, de Witte T, Kröger N. Impact of the revised International Prognostic Scoring System cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation. Haematologica. 2014 Dec 31. pii: haematol.2014.116715. [Epub ahead of print] PubMed PMID: 25552702.

Robin M, Ruggeri A, Labopin M, Niederwieser D, Tabrizi R, Sanz G, Bourhis J,van Biezen A, Koenecke C, Blaise D, Tischer J, Craddock C, Maillard N, Mohty M,Russel N, Schetelig J, Finke J, Gluckman E, de Witte TM, Rocha V, Kroger N. Comparison of Unrelated Cord Blood and Peripheral Blood Stem Cell Transplantation in Adults with Myelodysplastic Syndrome after Reduced-Intensity Conditioning Regimen: A Collaborative Study from Eurocord and Chronic Malignancies Working Party. Biol Blood Marrow Transplant. 2014 Dec 19. pii: S1083-8791(14)01384-6. doi: 10.1016/j.bbmt.2014.11.675. [Epub ahead of print] PubMed PMID: 25529382.

Heuser M, Schlarmann C, Dobbernack V, Panagiota V, Wiehlmann L, Walter C, Beier F, Ziegler P, Yun H, Kade S, Kirchner A, Huang L, Koenecke C, Eder M, Brümmendorf TH, Dugas M, Ganser A, Thol F. Genetic characterization of acquired aplastic anemia by targeted sequencing. Haematologica. 2014 Jun 6. pii: haematol.2013.101642. [Epub ahead of print] PubMed PMID: 24907358.

Heuser M, Panagiota V, Koenecke C, Fehse B, Alchalby H, Badbaran A, Shahswar R, Stadler M, Eder M, Göhring G, Trummer A, Schroeder T, Kobbe G, Thiede C, Platzbecker U, Schlegelberger B, Kroeger N, Ganser A, Thol F. Low frequency of calreticulin mutations in MDS patients. Leukemia. 2014 May 21. doi: 10.1038/leu.2014.165. [Epub ahead of print] PubMed PMID: 24850292.

Panagiota V, Thol F, Markus B, Fehse B, Alchalby H, Badbaran A, Lehmann U,Koenecke C, Shahswar R, Chaturvedi A, Stadler M, Eder M, Göhring G, Koenigsmann M, Kloos A, Trummer A, Schroeder T, Kobbe G, Thiede C, Platzbecker U,Schlegelberger B, Kreipe HH, Ganser A, Kröger N, Heuser M. Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation. Leukemia. 2014 Feb 7. doi: 10.1038/leu.2014.66. [Epub ahead of print] PubMed PMID: 24504025.

Koenecke C, Pischke S, Beutel G, Ritter U, Ganser A, Wedemeyer H, Eder M. Hepatitis E virus infection in a hematopoietic stem cell donor. Bone Marrow Transplant. 2013 Sep 23. doi: 10.1038/bmt.2013.148. [Epub ahead of print] PubMed PMID: 24056741.


2013:


Prinz I, Thamm K, Port M, Weissinger EM, Stadler M, Gabaev I, Jacobs R, Ganser A, Koenecke C. Donor Vdelta1+ gammadelta T cells expand after allogeneic hematopoietic stem cell transplantation and show reactivity against CMV-infected cells but not against progressing B-CLL. Exp Hematol Oncol. 2013 May 11;2(1):14. [Epub ahead of print] PubMed PMID: 23663319.


Thol F, Suchanek KJ, Koenecke C, Stadler M, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Kade S, Löffeld P, Banihosseini S, Bug G, Ottmann O, Hofmann WK, Krauter J, Kröger N, Ganser A, Heuser M. SETBP1 mutation analysis in 944 patients with MDS and AML. Leukemia. 2013 May 7. doi: 10.1038/leu.2013.145. [Epub ahead of print] PubMed PMID: 23648668. 

2012:

Klyuchnikov E, Holler E, Bornhäuser M, Kobbe G, Nagler A, Shimoni A, Könecke C, Wolschke C, Bacher U, Zander AR, Kröger N. Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting. Br J Haematol. 2012 Aug 22. doi: 10.1111/bjh.12013. [Epub ahead of print] PubMed PMID: 22909192.

 

 

2011:

 

 

Föhse L, Suffner J, Suhre K, Wahl B, Lindner C, Lee CW, Schmitz S, Haas JD, Lamprecht S, Koenecke C, Bleich A, Hämmerling GJ, Malissen B, Suerbaum S, Förster R, Prinz I.  High TCR Diversity ensures optimal Function and Homeostasis of FoxP3+ Regulatory T cells. Eur J Immunol. 2011 Sep 19. doi: 10.1002/eji.201141986. [Epub ahead of print]

 

David S, Park JK, Meurs M, Zijlstra JG, Koenecke C, Schrimpf C, Shushakova N, Gueler F, Haller H, Kümpers P. Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis. Cytokine. 2011 Aug;55(2):251-9. Epub 2011 Apr 30. PMID: 21531574

 

Seth S, Ravens I, Lee CW, Glage S, Bleich A, Forster R, Bernhardt G, Koenecke C. (2011). Absence of CD155 aggravates acute graft-versus-host disease. Proc Natl Acad Sci U S A. PMID: 21321238

 

 

2010

Schwarz A, Haller H, Schmitt R, Schiffer M, Koenecke C, Strassburg C, Lehner F, Gottlieb J, Bara C, Becker JU, Broecker V. (2010). Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues. Am J Transpl. 10, 2017-25

 

Koenecke C, Hertenstein B, Schetelig J, van Biezen A, Dammann E, Gratwohl A, Ganser A, Schleuning M, Bornhäuser M, Jacobsen N, Kröger N, Niederwieser N, de Witte T, Ruutu T. (2010). Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: A retrospective, multicenter study of the EBMT. Am J Transpl. 10, 1897-906.

 

Koenecke C*, Kümpers P*, Lukasz A, Dammann E, Verhagen W, Göhring G, Buchholz S, Krauter J, Eder M, Schlegelberger B, Ganser, A. (2010). Shedding of the endothelial receptor tyrosine-kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem-cell transplantation for AML Ann Hematol. 89, 459-67.*contributed equally

 

Dahl D, Hahn H, Koenecke C, Heuft H, Dammann E, Stadler M, Buchholz S, Krauter J, Eder M, Sykora K, Klein C, Ganser A, Sauer M. (2010). Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk. Transfusion.  50, 649-55.

 

2009

 

Koenecke C, Czeloth N, Bubke A, Schmitz S, Kissenpfennig A, Malissen B, Huehn J, Ganser A, Förster R, Prinz I. (2009). Alloantigen-specific de novo-induced Foxp3(+) Treg revert in vivo and do not protect from experimental GVHD. Eur J Immunol. 39, 3091-3096.

 

Voedisch S, Koenecke C, David S, Herbrand H, Förster R, Rhen M, Pabst O. (2009). Mesenteric lymph nodes confine dendritic cell-mediated dissemination of Salmonella enterica serovar Typhimurium and limit systemic disease in mice. Infect Immun. 77, 3170-80.

 

Ghosh A, Koestner W, Hapke M, Schlaphoff V, Länger F, Baumann R, Koenecke C, Cornberg M, Welte K, Blazar BR, Sauer MG. (2009). Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras. Blood. 113, 4440-8.

 

Ukena SN*, Koenecke C*, Geffers R, Fuehner T, Welte T, Ganser A, Buer J, Franzke A. (2009). T helper type 2 differentiation is associated with induction of antibacterial defense mechanisms in blood lymphocytes of patients with sarcoidosis.. Immunol Invest. 38, 49-66 *contributed equally

 

Koenecke C, Chennupati V, Schmitz S, Malissen B, Förster R, Prinz I. (2009). In vivo application of mAb directed against the gammadelta TCR does not deplete but generates "invisible" gammadelta T cells. Eur J Immunol. 39, 372-9.

 

Li Z, Beutel G, Rhein M, Meyer J, Koenecke C, Neumann T, Yang M, Krauter J, von Neuhoff N, Heuser M, Diedrich H, Göhring G, Wilkens L, Schlegelberger B, Ganser A, Baum C. (2009). High-affinity neurotrophin receptors and ligands promote leukemogenesis. Blood. 113, 2028-37.

 

Lovric S, Erdbruegger U, Kümpers P, Woywodt A, Koenecke C, Wedemeyer H, Haller H, Haubitz M. (2009). Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients. Nephrol Dial Transplant. 24, 179-85.

 

2008

 

Kümpers P*, Koenecke C*, Hecker H, Hellpap J, Horn R, Verhagen W, Buchholz S, Hertenstein B, Krauter J, Eder M, David S, Göhring G, Haller H, Ganser A. (2008). Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies. Blood. 112, 2139-48. *contributed equally

 

Koenecke C, Hofmann M, Bolte O, Gielow P, Dammann E, Stadler M, Franzke A, Boerner AR, Eder M, Ganser A, Knapp W, Hertenstein B. (2008). Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia. Int J Hematol. 87, 414-21.

 

Buchholz S, Dammann E, Koenecke C, Stadler M, Franzke A, Blasczyk R, Bremer M, Krauter J, Hertenstein B, Ganser A, Eder M. (2008). Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults- a single-centre experience. Ann Hematol. 87, 551-6.

 

2006

 

Franzke A, Koenecke C, Geffers R, Piao W, Hunger JK, Ganser A, Buer J. (2006). Classical Hodgkin's lymphoma: molecular evidence for specific alterations in circulating T lymphocytes. Tumour Biol. 27, 329-33.

 

Koenecke C*, Kleine M*, Schrem H, Krug U, Nashan B, Neipp M, Ganser A, Hertenstein B, Klempnauer J. (2006). Sinusoidal obstruction syndrome of the liver after hematopoietic stem cell transplantation: decision making for orthotopic liver transplantation. Int J Hematol. 83, 271-4. *contributed equally

 

2003

 

Franzke A, Piao W, Lauber J, Gatzlaff P, Könecke C, Hansen W, Schmitt-Thomsen A, Hertenstein B, Buer J, Ganser A. (2003). G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood. 102, 734-9.

 

Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, Saidman SL, Dey B, McAfee S, Spitzer TR, Sykes M. (2003). NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507. Exp Hematol. 31, 911-23.

  

  

AG Könecke

Projekte

Mitarbeiter*innen


PFLEGE-STELLENTICKER

Werden Sie Teil des Pflege-Teams der MHH. Mehr Infos in unserem Stellenticker. Wir freuen uns auf ...

[mehr]